The historical data from 2013 to 2023 shows an initial strong year-on-year growth in antiretroviral therapy coverage in South Africa, with year-on-year variations falling from 12.2% to 0% over the period. The compound annual growth rate (CAGR) experienced a similar decline from 26.86% to 1.12%. By 2023, coverage stood at 74% and remained stagnant, as forecasted, up to 2028. This plateau suggests a saturation point has been reached or challenges in further increasing coverage.
Future trends to watch for include potential innovative treatment offerings, policy changes, and healthcare infrastructure improvements that could drive a resurgence in growth. Monitoring the impact of such changes will be crucial for understanding their effectiveness and forecasting subsequent coverage trends.
